Clinical Trial Update: Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intravenous versus oral lansoprazole in patients with erosive esophagitis and gastroesophageal reflux disease to evaluate gastric acid s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Takeda | Conditions: Esophagitis, Reflux | Phase 2 | Status: COMPLETED